[Fever in the neutropenic patient].
作者信息
Milpied N
机构信息
Service d'hématologie CHU de Nantes 44035 Nantes.
出版信息
Rev Prat. 2001 Mar 31;51(6):633-7.
PMID:11345865
Abstract
The neutropenic patient, whatever the cause of neutropenia (drug related, secondary to marrow involvement by malignant disease or to cytotoxic treatment) is at high risk of bacterial and fungal infection. The first symptom (and often the only one) of infection is fever. The guidelines for management of the febrile neutropenic patient are precise and simple and have been widely accepted for more than 30 years allowing a dramatic decrease of the infectious mortality during episodes of neutropenia.
摘要
相似文献
1
[Fever in the neutropenic patient].
Rev Prat. 2001 Mar 31;51(6):633-7.
2
A European Organization for Research and Treatment of Cancer-International Antimicrobial Therapy Group Study of secondary infections in febrile, neutropenic patients with cancer.欧洲癌症研究与治疗组织-国际抗菌治疗小组对发热性中性粒细胞减少癌症患者继发感染的研究。
Clin Infect Dis. 2005 Jan 15;40(2):239-45. doi: 10.1086/426815. Epub 2004 Dec 20.
3
Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.日本不明原因发热的中性粒细胞减少症患者管理临床指南：日本发热性中性粒细胞减少症研究组的验证
Int J Antimicrob Agents. 2005 Dec;26 Suppl 2:S123-7; discussion S133-40. doi: 10.1016/j.ijantimicag.2005.08.001. Epub 2005 Oct 24.
4
[Febrile neutropenia in the child with cancer. Current concepts about risk assessment and selective management].[癌症患儿的发热性中性粒细胞减少症。关于风险评估和选择性管理的当前概念]
Rev Med Chil. 2001 Dec;129(12):1449-54.
5
[Antimicrobial prophylaxis and therapy in neutropenia].[中性粒细胞减少症的抗菌预防与治疗]
Mycoses. 2003;46 Suppl 2:21-32.
6
Febrile neutropenia in haematological malignancies.血液系统恶性肿瘤中的发热性中性粒细胞减少症。
J Postgrad Med. 2005;51 Suppl 1:S42-8.
7
Management of the febrile neutropenic patient.发热性中性粒细胞减少症患者的管理。
Int J Antimicrob Agents. 2005 Dec;26 Suppl 2:S120-2; discussion S133-40. doi: 10.1016/j.ijantimicag.2005.07.010. Epub 2005 Oct 21.
8
Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.对需要住院治疗的癌症发热性中性粒细胞减少患者的治疗：一项比较亚胺培南和头孢吡肟的前瞻性随机研究。
Cancer. 2003 Sep 1;98(5):1039-47. doi: 10.1002/cncr.11613.
9
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?发热性中性粒细胞减少症的变化面貌——从单一疗法到霉菌感染再到粘膜炎。为何采用经验性治疗？
J Antimicrob Chemother. 2009 May;63 Suppl 1:i14-5. doi: 10.1093/jac/dkp075.
10
Management of the febrile neutropenic cancer patient: lessons from 40 years of study.
Clin Microbiol Infect. 2005 Oct;11 Suppl 5:24-9. doi: 10.1111/j.1469-0691.2005.01240.x.
Zotero 插件